ExodusPoint Capital Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-115,584
Closed -$313K 1747
2025
Q4
$313K Buy
+115,584
New +$379K ﹤0.01% 1304
2025
Q2
Sell
-21,617
Closed -$95K 1635
2025
Q1
$95K Sell
21,617
-47,660
-69% -$224K ﹤0.01% 1346
2024
Q4
$322K Buy
+69,277
New +$381K ﹤0.01% 1258
2023
Q4
Sell
-116,384
Closed -$655K 1676
2023
Q3
$655K Sell
116,384
-814,289
-87% -$5.43M 0.01% 1139
2023
Q2
$5.14M Sell
930,673
-85,235
-8% -$459K 0.04% 441
2023
Q1
$6.35M Buy
1,015,908
+642,563
+172% +$3.58M 0.05% 430
2022
Q4
$1.74M Sell
373,345
-196,897
-35% -$970K 0.03% 707
2022
Q3
$2.66M Buy
570,242
+302,553
+113% +$1.91M 0.03% 651
2022
Q2
$1.58M Buy
267,689
+236,685
+763% +$2.63M 0.02% 885
2022
Q1
$599K Buy
31,004
+18,739
+153% +$430K 0.01% 1430
2021
Q4
$401K Buy
+12,265
New +$493K ﹤0.01% 1533
2021
Q1
Sell
-60,004
Closed -$2.42M 2276
2020
Q4
$2.42M Buy
60,004
+49,082
+449% +$2.25M 0.02% 464
2020
Q3
$607K Buy
+10,922
New +$578K 0.01% 917

Other funds holding GDRX

ExodusPoint Capital Management's GDRX Position: Q1 2026 in Review

ExodusPoint Capital Management sold out of GoodRx Holdings (GDRX) in Q1 2026, closing a stake of 115,584 shares — an estimated $313K sold.

ExodusPoint Capital Management first reported a position in GDRX in Q3 2020 and held it in 13 quarters. The position peaked at $6.35M in Q1 2023. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • ExodusPoint Capital Management reported no remaining GoodRx Holdings position as of Q1 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 115,584 GoodRx Holdings shares in Q1 2026, an estimated $313K.
  • ExodusPoint Capital Management first reported a position in GoodRx Holdings in Q3 2020 and held it in 13 quarters.
  • ExodusPoint Capital Management's GoodRx Holdings position peaked at $6.35M in Q1 2023.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.